These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7711060)

  • 1. Phosphorylation of the C-terminal domain of RNA polymerase II.
    Dahmus ME
    Biochim Biophys Acta; 1995 Apr; 1261(2):171-82. PubMed ID: 7711060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA polymerases IIA and IIO have distinct roles during transcription from the TATA-less murine dihydrofolate reductase promoter.
    Kang ME; Dahmus ME
    J Biol Chem; 1993 Nov; 268(33):25033-40. PubMed ID: 8227067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The repetitive C-terminal domain of RNA polymerase II: multiple conformational states drive the transcription cycle.
    Lin PS; Tremeau-Bravard A; Dahmus ME
    Chem Rec; 2003; 3(4):235-45. PubMed ID: 14595832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylation of RNA polymerase II by CTD-phosphatase FCP1 is inhibited by phospho-CTD associating proteins.
    Palancade B; Marshall NF; Tremeau-Bravard A; Bensaude O; Dahmus ME; Dubois MF
    J Mol Biol; 2004 Jan; 335(2):415-24. PubMed ID: 14672652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
    Guo Z; Stiller JW
    BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTD phosphatase: role in RNA polymerase II cycling and the regulation of transcript elongation.
    Lin PS; Marshall NF; Dahmus ME
    Prog Nucleic Acid Res Mol Biol; 2002; 72():333-65. PubMed ID: 12206456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of COOH-terminal domain phosphatase is regulated by a docking site on RNA polymerase II and by the general transcription factors IIF and IIB.
    Chambers RS; Wang BQ; Burton ZF; Dahmus ME
    J Biol Chem; 1995 Jun; 270(25):14962-9. PubMed ID: 7797476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1.
    Chun RF; Jeang KT
    J Biol Chem; 1996 Nov; 271(44):27888-94. PubMed ID: 8910388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity of RNA polymerase II in elongation complexes to C-terminal domain phosphatase.
    Lehman AL; Dahmus ME
    J Biol Chem; 2000 May; 275(20):14923-32. PubMed ID: 10809737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cis-acting elements that can obviate a requirement for the C-terminal domain of RNA polymerase II.
    Buermeyer AB; Strasheim LA; McMahon SL; Farnham PJ
    J Biol Chem; 1995 Mar; 270(12):6798-807. PubMed ID: 7896826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
    Baskaran R; Chiang GG; Wang JY
    Mol Cell Biol; 1996 Jul; 16(7):3361-9. PubMed ID: 8668151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation.
    Palancade B; Bensaude O
    Eur J Biochem; 2003 Oct; 270(19):3859-70. PubMed ID: 14511368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control.
    Oelgeschläger T
    J Cell Physiol; 2002 Feb; 190(2):160-9. PubMed ID: 11807820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.
    Zhou M; Deng L; Kashanchi F; Brady JN; Shatkin AJ; Kumar A
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12666-71. PubMed ID: 14569024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The photoactivated cross-linking of recombinant C-terminal domain to proteins in a HeLa cell transcription extract that comigrate with transcription factors IIE and IIF.
    Kang ME; Dahmus ME
    J Biol Chem; 1995 Oct; 270(40):23390-7. PubMed ID: 7559497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II.
    Buermeyer AB; Thompson NE; Strasheim LA; Burgess RR; Farnham PJ
    Mol Cell Biol; 1992 May; 12(5):2250-9. PubMed ID: 1569952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topological localization of the carboxyl-terminal domain of RNA polymerase II in the initiation complex.
    Douziech M; Forget D; Greenblatt J; Coulombe B
    J Biol Chem; 1999 Jul; 274(28):19868-73. PubMed ID: 10391932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc.
    Kelly WG; Dahmus ME; Hart GW
    J Biol Chem; 1993 May; 268(14):10416-24. PubMed ID: 8486697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability.
    Chapman RD; Palancade B; Lang A; Bensaude O; Eick D
    Nucleic Acids Res; 2004; 32(1):35-44. PubMed ID: 14704341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.